Patents by Inventor Sten HAMMARSTRÖM

Sten HAMMARSTRÖM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MARKER GENES FOR COLORECTAL CANCER CLASSIFICATION, METHOD FOR JUDGING LYMPH NODE METASTASIS FOR PROGNOSIS OF COLORECTAL CANCER AND KIT THEREFOR
    Publication number: 20210246513
    Abstract: A group of molecular biomarkers having the genes SLC35D3, POSTN, KLK6 and MUC2 can be used in objective and quantitative methods for the classification, prediction of prognosis and for guiding treatment decisions of a subject with colorectal cancer. More specifically, a method for determining the metastatic potential and/or tumor aggressiveness of a colorectal cancer in a subject can include determining the gene expression levels of genes SLC35D3, POSTN, KLK6 and/or MUC2 in a regional lymph node, a primary intestinal tumor, blood, or feces sample obtained from the subject.
    Type: Application
    Filed: March 24, 2021
    Publication date: August 12, 2021
    Applicant: HiloProbe AB
    Inventors: Lina Olsson, Sten Hammarström, Marie-Louise Hammarström, Gudrun Lindmark, Anne Israelsson
  • Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor
    Patent number: 10988811
    Abstract: A group of molecular biomarkers having the genes SLC35D3, POSTN, KLK6 and MUC2 can be used in objective and quantitative methods for the classification, prediction of prognosis and for guiding treatment decisions of a subject with colorectal cancer. More specifically, a method for determining the metastatic potential and/or tumor aggressiveness of a colorectal cancer in a subject can include determining the gene expression levels of genes SLC35D3, POSTN, KLK6 and/or MUC2 in a regional lymph node, a primary intestinal tumor, blood, or feces sample obtained from the subject.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: April 27, 2021
    Assignee: HiloProbe AB
    Inventors: Lina Olsson, Sten Hammarström, Marie-Louise Hammarström, Gudrun Lindmark, Anne Israelsson
  • MARKER GENES FOR COLORECTAL CANCER CLASSIFICATION, METHOD FOR JUDGING LYMPH NODE METASTASIS FOR PROGNOSIS OF COLORECTAL CANCER AND KIT THEREFOR
    Publication number: 20190136328
    Abstract: A group of molecular biomarkers having the genes SLC35D3, POSTN, KLK6 and MUC2 can be used in objective and quantitative methods for the classification, prediction of prognosis and for guiding treatment decisions of a subject with colorectal cancer. More specifically, a method for determining the metastatic potential and/or tumor aggressiveness of a colorectal cancer in a subject can include determining the gene expression levels of genes SLC35D3, POSTN, KLK6 and/or MUC2 in a regional lymph node, a primary intestinal tumor, blood, or feces sample obtained from the subject.
    Type: Application
    Filed: April 12, 2017
    Publication date: May 9, 2019
    Applicant: HiloProbe AB
    Inventors: Lina OLSSON, Sten HAMMARSTRÖM, Marie-Louise HAMMARSTRÖM, Gudrun LINDMARK, Anne ISRAELSSON